Primary and secondary dysmenorrhea: symptoms, risk factors, diagnosis, and treatment – review
DOI:
https://doi.org/10.12775/QS.2024.21.53346Keywords
primary dysmenorrhea, secondary dysmenorrhea, painful menstruation, dysmenorrhea risk, dysmenorrhea treatments, dysmenorrhea diagnosisAbstract
Dysmenorrhea, or painful uterine contractions during menstruation in women, is a common condition. It may affect up to 90% of patients in a doctor's office. Depending on the severity of symptoms, it may cause discomfort or prevent normal functioning in everyday life. Some women do not realize that this is not a normal symptom during menstruation. Unfortunately, lack of exercise, smoking, or drinking alcohol only increases the symptoms. A medical history and physical examination of the patient are important steps in finding the cause. Primary dysmenorrhea is primarily associated with the pathogenesis of prostaglandins and leukotrienes, which generate inflammation and pain. However, it has nothing to do with pelvic pathology. It usually first appears in young women during puberty, up to 24 months after their first period. If the history and physical examination are not clear about the primary cause of pain, a secondary cause should be considered. For this purpose, a transvaginal ultrasound examination should be performed. The most common secondary pathology is endometriosis. In the treatment of primary and secondary diseases, physical exercises and warm compresses are beneficial, which women are often unaware of. First-line pharmacological treatment may include NSAIDs or combined oral estrogen-progestogen hormonal therapy. The purpose of this review is to provide knowledge about the symptoms, risk factors, diagnosis, and treatment of dysmenorrhea.
References
Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21(6):762-778. https://doi:10.1093/humupd/dmv039.
ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018;132(6):e249-e258. https://doi:10.1097/AOG.0000000000002978.
Al-Jefout M, Nawaiseh N. Continuous Norethisterone Acetate versus Cyclical Drospirenone 3 mg/Ethinyl Estradiol 20 μg for the Management of Primary Dysmenorrhea in Young Adult Women. J Pediatr Adolesc Gynecol. 2016;29(2):143-147. https://doi:10.1016/j.jpag.2015.08.009.
McKenna KA, Fogleman CD. Dysmenorrhea. Am Fam Physician. 2021;104(2):164-170.
Nagy H, Carlson K, Khan MAB. Dysmenorrhea. StatPearls Publishing https://www.ncbi.nlm.nih.gov/books/NBK560834/ (access: 2024.06.01).
De Sanctis V, Soliman A, Bernasconi S, et al. Primary Dysmenorrhea in Adolescents: Prevalence, Impact and Recent Knowledge. Pediatr Endocrinol Rev. 2015;13(2):512-520.
Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. J Obstet Gynaecol Can. 2017;39(7):585-595. https://doi:10.1016/j.jogc.2016.12.023.
Oladosu FA, Tu FF, Hellman KM. Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. Am J Obstet Gynecol. 2018;218(4):390-400. https://doi:10.1016/j.ajog.2017.08.108.
Kho KA, Shields JK. Diagnosis and Management of Primary Dysmenorrhea. JAMA. 2020; 323(3):268-269. https://doi:10.1001/jama.2019.16921.
Singh K, Srivastava D, Misra R et al. Relationship between primary dysmenorrhea and body composition parameters in young females. Int J Health Sci Res, 2015, 5.7: 150-155.
Itani R, Soubra L, Karout S, et al. Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates. Korean J Fam Med. 2022;43(2):101-108. https://doi:10.4082/kjfm.21.0103.
Mendiratta V, Lentz GM. Primary and secondary dysmenorrhea, premenstrual syndrome, and premenstrual dysphoric disorder. In: Lobo RA, Gershenson DM, Lentz GM, editors. 7th ed. Comprehensive gynecology. Philadelphia (PA): Elsevier Inc. 2017; p.815–828.
Latthe P, Mignini L, Gray R, et al. Factors predisposing women to chronic pelvic pain: systematic review. BMJ. 2006;332(7544):749-755. https://doi:10.1136/bmj.38748.697465.55.
Grandi G, Ferrari S, Xholli A, et al. Prevalence of menstrual pain in young women: what is dysmenorrhea?. J Pain Res. 2012;5:169-174. https://doi:10.2147/JPR.S30602.
Osayande AS, Mehulic S. Diagnosis and initial management of dysmenorrhea. Am Fam Physician. 2014;89(5):341-346.
Lundström V, Gréen K, Svanborg K. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility. Acta Obstet Gynecol Scand Suppl. 1979;87:51-56. https://doi:10.3109/00016347909157790.
Chan WY, Hill JC. Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects. Prostaglandins. 1978;15(2):365-375. https://doi:10.1016/0090-6980(78)90176-4.
Harel Z, Lilly C, Riggs S, et al. Urinary leukotriene (LT) E(4) in adolescents with dysmenorrhea: a pilot study. J Adolesc Health. 2000;27(3):151-154. https://doi:10.1016/s1054-139x(00)00123-3.
Bernardi M, Lazzeri L, Perelli F, et al. Dysmenorrhea and related disorders. F1000Res. 2017;6:1645. Published 2017 Sep 5. https://doi:10.12688/f1000research.11682.1.
Alsaleem MA. Dysmenorrhea, associated symptoms, and management among students at King Khalid University, Saudi Arabia: An exploratory study. J Family Med Prim Care. 2018;7(4):769-774. https://doi:10.4103/jfmpc.jfmpc_113_18.
Ferries-Rowe E, Corey E, Archer JS. Primary Dysmenorrhea: Diagnosis and Therapy. Obstet Gynecol. 2020;136(5):1047-1058. https://doi:10.1097/AOG.0000000000004096
de Las Mercedes Villa Rosero CY, Mazin SC, Nogueira AA et al. Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador. BMC Women's Health 22, 363 (2022). https://doi.org/10.1186/s12905-022-01948-y
Kędzia M, Besta P, Czajkowski K et al. Recommendations of the Polish Society of Gynecologists and Obstetricians regarding the management of women with endometriosis. Polish Society of Gynecologists and Obstetricians. Access 20.10.2023 https://www.ptgin.pl/sites/scm/files/2023-10/Rekomendacje%20ENDOMETRIOZA%2023.10.2023.png__1.pdf
Mobeen S, Apostol R. Ovarian Cyst. StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK560541/ (access: 2024.06.01).
Kim DY, Nam G, Lee SR, et al. Congenital Obstructive Müllerian Anomaly: The Pitfalls of a Magnetic Resonance Imaging-Based Diagnosis and the Importance of Intraoperative Biopsy. J Clin Med. 2021;10(11):2414. Published 2021 May 29. https://doi:10.3390/jcm10112414.
Ludwin A, Tudorache S, Martins WP. ASRM Müllerian Anomalies Classification 2021: a critical review. Ultrasound Obstet Gynecol. 2022;60(1):7-21. https://doi:10.1002/uog.24905.
Syed Khaja AS, Zafar M, Alshammari AMA, et al. Assessment of Knowledge and Attitude Toward Pelvic Inflammatory Disease Among Women in Saudi Arabia. Cureus. 2023;15(9): e45013. Published 2023 Sep 11. https://doi:10.7759/cureus.45013.
Li X, Sun Y, Wang Y, et al. Manual Therapy in Primary Dysmenorrhea: A Systematic Review and Meta-Analysis. J Pain Res. 2024;17:1663-1681. Published 2024 May 6. https://doi:10.2147/JPR.S457381.
Sharghi M, Mansurkhani SM, Larky DA, et al. An update and systematic review on the treatment of primary dysmenorrhea. JBRA Assist Reprod. 2019;23(1):51-57. Published 2019 Jan 31. https://doi:10.5935/1518-0557.20180083.
Ilmiah WS, Abdullah I, Koesrini J. Non-pharmacological that most effective to reduce of primary dysmenorrhea intensity in women childbearing age: a literature review. J Public Health Afr. 2023;14(12):2349. Published 2023 Dec 1. https://doi:10.4081/jphia.2023.2349.
Jo J, Lee SH. Heat therapy for primary dysmenorrhea: A systematic review and meta-analysis of its effects on pain relief and quality of life. Sci Rep. 2018;8(1):16252. Published 2018 Nov 2. https://doi:10.1038/s41598-018-34303-z.
Anggriani A, Mulyani Y, Pratiwi LD. The effect of pharmacological and non-pharmacological therapy on the reduction of menstrual pain in students of the faculty of pharmacy, Bhakti Kencana University, Bandung. Jurnal Riset Kefarmasian Indonesia 2021; 3(3):174-188. https://doi:10.33759/jrki.v3i3.156.
Aboualsoltani F, Bastani P, Khodaie L, et al. Non-pharmacological treatments of primary dysmenorrhea: A systematic review. Arch Pharmacy Pract 2020; 11: 136-142.
Yagci N, Senel A, Atalay OT, et al. Long-Term Follow-Up Result of Connective Tissue Manipulation in Young Women with Primary Dysmenorrhea: Different Intervention Durations. Reprod Sci. 2023;30(7):2198-2209. https://doi:10.1007/s43032-023-01172-5.
Fernández-Martínez E, Onieva-Zafra MD, Parra-Fernández ML. The Impact of Dysmenorrhea on Quality of Life Among Spanish Female University Students. Int J Environ Res Public Health. 2019;16(5):713. Published 2019 Feb 27. https://doi:10.3390/ijerph16050713.
Armour M, Ee CC, Naidoo D, et al. Exercise for dysmenorrhoea. Cochrane Database Syst Rev. 2019;9(9):CD004142. Published 2019 Sep 20. https://doi:10.1002/14651858.CD004142.pub4.
Matthewman G, Lee A, Kaur JG, et al. Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2018;219(3):255.e1-255.e20. https://doi:10.1016/j.ajog.2018.04.001.
Bayraktar M, Sincan S, Tanriverdi EC, et al. Primary dysmenorrhea and Yoga: A Mini - review. World J Yoga Phys Ther Rehabil 2020; 2(4):1-3. https://doi:10.33552/WJYPR.2020.02.000542.
Mirbagher-Ajorpaz N, Adib-Hajbaghery M, Mosaebi F. The effects of acupressure on primary dysmenorrhea: a randomized controlled trial. Complement Ther Clin Pract. 2011;17(1):33-36. https://doi:10.1016/j.ctcp.2010.06.005.
Blödt S, Pach D, Eisenhart-Rothe SV, et al. Effectiveness of app-based self-acupressure for women with menstrual pain compared to usual care: a randomized pragmatic trial. Am J Obstet Gynecol. 2018;218(2):227.e1-227.e9. https://doi:10.1016/j.ajog.2017.11.570.
Smith CA, Armour M, Zhu X, et al. Acupuncture for dysmenorrhoea. Cochrane Database Syst Rev. 2016;4(4):CD007854. Published 2016 Apr 18. https://doi:10.1002/14651858.CD007854.pub3.
Christensen K. Dysmenorrhoea: An update on primary healthcare management. Aust J Gen Pract. 2024;53(1-2):19-22. https://doi:10.31128/AJGP/04-23-6815.
Sinclair J, Abbott J, Proudfoot A, Armour M. The Place of Cannabinoids in the Treatment of Gynecological Pain. Drugs. 2023;83(17):1571-1579. doi:10.1007/s40265-023-01951-z
Seifalian A, Kenyon J, Khullar V. Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?. Int J Mol Sci. 2022;23(24):16201. Published 2022 Dec 19. doi:10.3390/ijms232416201
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Paulina Krzemińska, Joanna Kołodziej, Arkadiusz Biniewicz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 291
Number of citations: 0